NCT05898633View on ClinicalTrials.gov

Recombinant Surfactant Protein D (rfhSP-D) to Prevent Neonatal Chronic Lung Disease

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 6, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Lung Disease of PrematurityRespiratory Distress Syndrome in Premature InfantBronchopulmonary Dysplasia
Interventions
DRUG

Recombinant fragment of human surfactant protein D (rfhSP-D)

Administration of rfhSP-D

Trial Locations (1)

Unknown

University College London Hospitals, London

Sponsors

Collaborators (1)

Medical Research Council
All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

lead

University College, London

OTHER

NCT05898633 - Recombinant Surfactant Protein D (rfhSP-D) to Prevent Neonatal Chronic Lung Disease | Biotech Hunter | Biotech Hunter